Interferon Alpha's Role in Common Colds Unclear, Says Pediatrician
Interferon alpha, a protein crucial for immune response, has shown promise in treating serious viral infections. However, its effectiveness in common colds remains uncertain.
Interferon alpha, produced by the body in response to infections, has been recognised by the WHO as a key player against influenza. In high doses, as used in hospitals, it has proven antiviral activity. Yet, in small doses, such as those found in over-the-counter syrups and suppositories for common colds, its effectiveness is questionable.
Pediatrician Victor Tutyun stresses that time and patience are the most effective remedies for seasonal colds. Despite large-scale clinical trials, immunomodulators like interferon alpha have not shown definitive benefits for the flu or common cold. Antiviral drugs containing interferon alpha, like '-feron' medications, are typically reserved for specific viral infections and cancers, often in combination with other therapies.
While interferon alpha holds promise in serious viral infections, its role in treating common colds remains inconclusive. For now, time and patience are the best remedies for seasonal colds.
